Navigating Focal Therapy for Prostate Cancer: Contemporary Perspectives and Future Trajectories in the Canadian...

Area of Science:

• Urology
• Oncology
• Medical Technology

Background:

• Focal therapy (FT) represents a significant advancement in prostate cancer (PCa) treatment.
• Canadian urologists are increasingly adopting FT principles and exploring its outcomes.
• Understanding the current landscape, challenges, and future directions of FT in Canada is essential.

Purpose of the Study:

• To equip Canadian urologists with the latest advancements in focal therapy (FT) principles and outcomes.
• To provide an overview of the current landscape of FT in Canada.
• To identify challenges and future directions for FT implementation in Canada.

Main Methods:

• A nonsystematic literature review focusing on Canadian-led studies in urology and prostate cancer (PCa).
• Literature search conducted on PubMed, MEDLINE, and Google Scholar, finalized in April 2024.
• A survey of Canadian urologists and radiologists practicing FT regarding experiences, technology access, challenges, and reimbursement.

Main Results:

• Nationwide implementation of FT in Canada is limited by financial constraints and resource shortages.
• Only two Canadian provinces (Saskatchewan and Alberta) have billing codes for FT, restricting patient access.
• Canadian patients face limited access to FT compared to those in the US and Europe, often requiring out-of-pocket payment or clinical trial participation.

Conclusions:

• Despite slower adoption compared to global trends, Canadian urologists are actively advocating for provincial healthcare coverage for FT.
• Improvements in FT research quality and ongoing clinical trials may lead to broader acceptance within clinical guidelines.
• Equitable healthcare coverage and integration of FT into standard treatment options are vital to close the care gap for Canadian men with PCa.